Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.73 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.48 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3839653 | 1.00 | L3MBTL1 (0.73) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL805464 | 0.98 | L3MBTL1 (0.72) | L3MBTL1MEN1KMT2ATDP1ATM | |
| Hydrochloric Acid SCHEMBL28021541 | 0.95 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL9762642 | 0.93 | — | — | |
| SCHEMBL10663507 | 0.87 | L3MBTL1 (0.58) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL674671 | 0.87 | — | — | |
| SCHEMBL10534153 | 0.86 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL7837034 | 0.86 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL150076 | 0.86 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10535931 | 0.85 | L3MBTL1 (1.00) | L3MBTL1MEN1KMT2ATDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1476448-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2004-11-17 | — | — | EP | claimed |
| WO-2003070731-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2003-08-28 | — | — | WO | claimed |
| WO-2026087386-A1 | ROSIN DIESTER COMPOUNDS AND USES THEREOF | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4661972-A1 | TASTE-MODIFYING COMPOSITIONS AND USES THEREOF | Firmenich SA (CH) | 2025-12-17 | — | — | EP | disclosed |
| US-12291512-B2 | Oxime compounds as agonists of the muscarinic M1 and/or M4 receptor | NXERA PHARMA UK LIMITED (GB) | 2025-05-06 | — | — | US | disclosed |
| WO-2025078256-A1 | COMPOSITION | GIVAUDAN SA (CH) | 2025-04-17 | — | — | WO | disclosed |
| EP-4476211-A1 | ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 | Enliven Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-4452253-A2 | 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD | The Katholieke Universiteit Leuven (BE) | 2024-10-30 | — | — | EP | disclosed |
| WO-2024200399-A1 | TASTE-MODIFYING COMPOSITIONS AND USES THEREOF | FIRMENICH SA (CH) | 2024-10-03 | — | — | WO | disclosed |
| US-20240308989-A1 | PYRAN DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS | ORION CORP (FI) | 2024-09-19 | — | — | US | disclosed |
| US-12029739-B2 | SHP2 inhibitor and use thereof | KANAPH THERAPEUTICS INC. (KR) | 2024-07-09 | — | — | US | disclosed |
| EP-0089908-A1 | Process for producing carboxylic-acid anhydrides | RHONE-POULENC CHIMIE DE BASE (FR) | 1983-09-28 | — | — | EP | disclosed |
| EP-0050084-A1 | Preparation of carboxylic-acid anhydrides by carbonylation | RHONE-POULENC CHIMIE DE BASE (FR) | 1982-04-21 | — | — | EP | disclosed |
| EP-0018927-B1 | PROCESS FOR PREPARING CARBOXYLIC ACIDS BY CARBONYLATION | RHONE-POULENC CHIMIE DE BASE (FR) | 1982-02-24 | — | — | EP | disclosed |
| US-4234484-A | FROM ALKOXYLATED CYCLIC AMIDES USING AS A CATALYST A QUATERNARY AMMONIUM OR ALKALI METAL SALT OF TETRAFLUOROBORIC OR HEXAFLUOROPHOSPHORIC ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-11-18 | — | — | US | disclosed |
| EP-0018927-A1 | Process for preparing carboxylic acids by carbonylation | RHONE-POULENC CHIMIE DE BASE (FR) | 1980-11-12 | — | — | EP | disclosed |
| US-4149941-A | ELECTROLYTIC ALKOXYLATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-04-17 | — | — | US | disclosed |
| US-4118500-A | Fungicidal alkoxy mono- and dialkoxy N-substituted cyclic amines | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-10-03 | — | — | US | disclosed |
| US-4090024-A | Process for the production of skatylhydantoin | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1978-05-16 | — | — | US | disclosed |
| US-3960844-A | Preparation of 6-acylamino-2-methyl-2-halomethyl penams | ELI LILLY AND COMPANY (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12291512-B2 | Oxime compounds as agonists of the muscarinic M1 and/or M4 receptor | CHRM1, CHRM2, CHRM4 | L3MBTL1 2861/4885MEN1 920/4885KMT2A 2379/4885 |
| US-12029739-B2 | SHP2 inhibitor and use thereof | PTPN1, PTPN5, PTPN2 | L3MBTL1 2970/4885MEN1 3025/4885KMT2A 1019/4885 |
| US-20240308989-A1 | PYRAN DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS | CYP11B1, CYP11B2, CYP4A11 | L3MBTL1 1781/4885MEN1 1007/4885KMT2A 3526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.